# Enterprise Portal Owner Handoff

**Candidate:** PR 10, `backend/activate-forms-portal-sql`
**Review date:** 18 July 2026
**Status:** Local enterprise candidate validated; exact pushed-SHA CI and owner review pending

## What Is Ready

- One authenticated portal entry point with customer, employee, board and administrator modes.
- Vishal Chakravarty remains the protected all-scope administrator identity.
- 54 connected module contracts use one SQL-backed domain model.
- Customer ordering, support, returns and quality-complaint foundations are operational with synthetic data.
- Employee supplier, product, telesales and purchase-order foundations are operational.
- Executive modules use canonical evidence and honest planned/no-data states.
- Administrator lead, account-application, local email, user/session, content and analytics controls are connected.
- The 19-item Nutraxin catalogue, six ranges, 95 media assets and evidence restrictions are integrated.
- SQLite migration 004 and Azure SQL migration 004 are aligned.
- Backup and isolated restoration tests pass.

## Owner Review Route

After the protected local runtime is started, use `/admin/local-review/` to inspect every module by audience. Use only the existing protected credential handoff; never place the password in source, documentation, chat or screenshots.

Recommended review sequence:

1. Public Nutraxin catalogue wording and product transcriptions.
2. Customer account, products, prices, stock, orders, invoices, returns and quality cases.
3. Employee product, purchasing, warehouse, finance, quality, regulatory and CRM views.
4. Executive Platform source-status and planned-capability disclosures.
5. Administrator lead/application review, email capture, sessions and content controls.

## Explicit Non-Production Boundaries

- All operational records are synthetic TEST/DEMO records.
- No external email is sent.
- No SharePoint, Microsoft Graph, NHS, warehouse, tender, safety or AI integration is represented as live.
- No Nutraxin price, stock, availability or approved health claim is published.
- No production customer, supplier, board or pharmaceutical trading data should be entered.
- PR 10 remains unmerged until the owner separately approves it.

## Validation Completed

1. Chromium and WebKit completed 1,316 rendered page states, 1,316 Axe scans and 1,464 screenshots with zero final issues.
2. Contact, account application, upload, local email preview and administrator review passed in both engines.
3. The official npm production advisory query reported zero vulnerabilities.
4. Repository and Gitleaks scans passed the 3.48 GB current tree and all pre-final reachable commits with zero findings.
5. The owner runtime created and verified a fresh pre-migration backup, reached live/ready, and retained the existing credential fingerprint, credential version, permanent-password state, four scopes and session set unchanged.
6. The owner-local suite passed every protected route and the authentication, session, form, document and isolation controls.
7. A fresh database backup was verified, restored in isolation and reconciled without changing the source database.

## Remaining Acceptance Gates

1. Commit and push this verified candidate.
2. Require all PR 10 workflows to pass against the exact pushed SHA.
3. Complete the owner's visual/content review through the protected localhost portal.
4. Keep PR 10 open and unmerged until separate owner approval.

No Azure deployment, DNS change, GitHub Pages change, SharePoint permission change or production integration is authorised by this local handoff.
